Healthcare / Pharmaceutical RetailersUpdated 2026-05-10 22:07 UTC

IDX/PEVE stock hub

IDX/PEVE has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

IDX/PEVEis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

653.3B

Indonesia Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

IDX/PEVE

In the news

Latest news · IDX/PEVE

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 9.4P50 14.4P75 23.9

Trailing P/E11.5

P25 11.5P50 23.8P75 52.6

ROE16.7

P25 0.6P50 5.1P75 12.2

ROIC9.7

P25 1.3P50 6P75 11.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All IDX/PEVE market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

190

Groups with data

Currency

IDR

Showing 190 of 190 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Indonesia
Country code	ID
Employees	1,218
Employees Change	247%
Employees Change Percent	25.44
Enterprise value	IDR 1T
Exchange	Indonesia Stock Exchange
Financial currency	IDR
First seen	2026-05-10
Industry	Pharmaceutical Retailers
Last refreshed	2026-05-10
Market cap	IDR 653.3B
Price	IDR 370
Price currency	IDR
Rev Per Employee	3,038,474,617.37x
Sector	Healthcare
Sic	5122
Symbol	idx/PEVE
Website	https://www.pentavalent.co.id

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	8.59%
EV Earnings	18.68x
EV/EBIT	11.82x
EV/EBITDA	10.45x
EV/FCF	-7.71x
EV/Sales	0.29x
FCF yield	-20.81%
P/B ratio	1.8x
P/E ratio	11.48x
P/S ratio	0.18x
PE Ratio3 Y	11.11x
PE Ratio5 Y	11.11x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	2.48%
EBITDA Margin	2.56%
Gross margin	10.73%
Gross Profit	IDR 384.1B
Gross Profit Growth	7.73%
Gross Profit Growth Q	9.63%
Gross Profit Growth3 Y	14.86%
Net Income	IDR 56.1B
Net Income Growth	7%
Net Income Growth Q	5.43%
Net Income Growth3 Y	29.87%
Pretax Margin	2.01%
Profit Margin	1.57%
Profit Per Employee	IDR 47.7M
ROA	4.22
Roa5y	3.83
ROCE	22.52
ROE	16.74
Roe5y	18.3
ROIC	9.69
Roic5y	14.24

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	5.06%
Cagr3y	30.05%
EPS Growth	6.64
EPS Growth Q	5.43
EPS Growth3 Y	20.42
Revenue Growth	14.05x
Revenue Growth Q	3.73x
Revenue Growth3 Y	17.93x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	IDR 2.72
Assets	IDR 1.4T
Cash	IDR 11.5B
Current Assets	IDR 1.3T
Current Liabilities	IDR 976B
Debt	IDR 406.4B
Debt EBITDA	IDR 4.05
Debt Equity	IDR 1.12
Debt FCF	IDR -2.99
Equity	IDR 362.7B
Interest Coverage	4.24
Liabilities	IDR 1T
Long Term Assets	IDR 42.1B
Long Term Liabilities	IDR 31.3B
Net Cash	IDR -394.8B
Net Cash By Market Cap	IDR -60.44
Net Debt EBITDA	IDR 4.31
Net Debt Equity	IDR 1.09
Tangible Book Value	IDR 361.9B
Tangible Book Value Per Share	IDR 205
WACC	4.03

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.36
Inventory Turnover	7.79
Net Working Capital	IDR 746.5B
Quick ratio	0.75
Working Capital	IDR 351.8B
Working Capital Turnover	IDR 11.11

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.33%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	5.06%
200-day SMA	486.1
3Y total return	120%
50-day SMA	478.3
50-day SMA vs 200-day SMA	50under200
All Time High	740
All Time High Change	-49.46%
All Time High Date	2025-09-30
All Time Low	135
All Time Low Change	177.04%
All Time Low Date	2023-08-18
ATR	30.99
Beta	-0.04
Beta1y	0.22
Beta2y	0
Ch YTD	-32
High	400
High52	740
High52 Date	2025-09-30
High52ch	-50%
Low	360
Low52	308
Low52 Date	2025-07-08
Low52ch	20.13%
Ma50ch	-21.81%
Price vs 200-day SMA	-23.06%
RSI	23.2
RSI Monthly	48.67
RSI Weekly	28.72
Sharpe ratio	0.69x
Sortino ratio	1.26
Total Return	-0.33%
Tr YTD	-32
Tr1m	-20.43%
Tr1w	-4.1%
Tr3m	-31.38%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	IDR 88.7B
Operating Income Growth	22.58
Operating Income Growth Q	9.94
Operating Income Growth3 Y	32.45
Operating margin	2.48

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	324,875,000%
Net Borrowing	148,228,096,888
Shares Insiders	1.6%
Shares Out	1,765,625,000
Shares Qo Q	4.16%
Shares Yo Y	0.33%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	IDR -136B
Average Volume	279,135x
Bv Per Share	205
CAPEX	IDR -3.6B
Ch1m	-20.43
Ch1w	-4.1
Ch1y	5.06
Ch3m	-31.38
Ch3y	120
Ch6m	-25.94
Change	-2.63%
Change From Open	-2.63
Close	380
Days Gap	0
Depreciation Amortization	2,784,919,908
Dollar Volume	275,539,000
Earnings Date	2026-05-13
EBIT	IDR 88.7B
EBITDA	IDR 91.5B
EPS	IDR 32.22
F Score	3
FCF	IDR -136B
FCF EV Yield	-12.96x
FCF Per Share	IDR -77.01
Financing CF	149,508,096,888
Fiscal Year End	December
Founded	1,968
Graham Number	385.49821
Graham Upside	4.19
Income Tax	IDR 16.3B
Investing CF	-13,043,924,115
Is Primary Listing	1
Last Earnings Date	2025-10-30
Last Report Date	2026-03-31
Lynch Fair Value	IDR 806
Lynch Upside	117.7
Ma150	511
Ma150ch	-26.81%
Ma20	436.4
Ma20ch	-14.3%
Net CF	4,057,536,638
Next Earnings Date	2026-05-13
Open	380
Position In Range	25
Ppne	27,108,668,236
Price Date	2026-05-08
Price EBITDA	IDR 7.14
Ptbv Ratio	1.81
Relative Volume	2.67x
Revenue	3,579,323,099,264x
Tax By Revenue	0.46x
Tax Rate	22.67%
Tr6m	-25.94%
Volume	744,700
Z Score	3.79

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does IDX/PEVE pay a dividend?

Capital-return profile for this ticker.

Performance

IDX/PEVE stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns IDX/PEVE?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+1.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.3%

Negative means the company is buying back shares.

Technical

IDX/PEVE momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

23.2

Below 30: short-term oversold

Price vs 200-day MA

-23.1%

50/200-day relationship not available

Beta (5Y)

-0.04

Less volatile than the market

Sharpe ratio

0.69

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About IDX/PEVE

Hub-level FAQ points readers to the deeper analysis pages.

What is the current idx/PEVE stock rating?

idx/PEVE is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full idx/PEVE analysis?

The full report lives at /stocks/idx/PEVE/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for idx/PEVE?

The latest report frames idx/PEVE around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the idx/PEVE page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.